| __timestamp | Arrowhead Pharmaceuticals, Inc. | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 175000 | 519428000 |
| Thursday, January 1, 2015 | 382000 | 906794000 |
| Friday, January 1, 2016 | 158333 | 1491717000 |
| Sunday, January 1, 2017 | 31407709 | 2213533000 |
| Monday, January 1, 2018 | 16142321 | 2638058000 |
| Tuesday, January 1, 2019 | 168795577 | 3615063000 |
| Wednesday, January 1, 2020 | 87992066 | 5469383000 |
| Friday, January 1, 2021 | 138287000 | 6670200000 |
| Saturday, January 1, 2022 | 232810000 | 7850400000 |
| Sunday, January 1, 2023 | 240735000 | 8607000000 |
| Monday, January 1, 2024 | 3551000 | 9489600000 |
Igniting the spark of knowledge
Over the past decade, the biopharmaceutical industry has witnessed remarkable growth, with companies like Vertex Pharmaceuticals Incorporated and Arrowhead Pharmaceuticals, Inc. leading the charge. From 2014 to 2023, Vertex Pharmaceuticals has consistently demonstrated robust financial performance, with gross profits soaring from approximately $519 million in 2014 to an impressive $8.6 billion in 2023. This represents a staggering increase of over 1,500%, underscoring Vertex's dominance in the sector.
In contrast, Arrowhead Pharmaceuticals, while showing growth, has experienced more modest gains. Starting with a gross profit of around $175,000 in 2014, Arrowhead reached $240 million by 2023, marking a significant yet smaller increase. The data highlights the dynamic nature of the biopharmaceutical landscape, where innovation and strategic investments drive financial success. Notably, 2024 data for Vertex is missing, indicating potential future updates or developments.
Gross Profit Analysis: Comparing Gilead Sciences, Inc. and Vertex Pharmaceuticals Incorporated
Gross Profit Analysis: Comparing Vertex Pharmaceuticals Incorporated and Jazz Pharmaceuticals plc
R&D Spending Showdown: Vertex Pharmaceuticals Incorporated vs Arrowhead Pharmaceuticals, Inc.
Vertex Pharmaceuticals Incorporated or Arrowhead Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Who Generates Higher Gross Profit? Takeda Pharmaceutical Company Limited or Arrowhead Pharmaceuticals, Inc.
Key Insights on Gross Profit: Biogen Inc. vs Arrowhead Pharmaceuticals, Inc.
Gross Profit Trends Compared: United Therapeutics Corporation vs Arrowhead Pharmaceuticals, Inc.
Gross Profit Analysis: Comparing Incyte Corporation and Arrowhead Pharmaceuticals, Inc.
Gross Profit Trends Compared: Halozyme Therapeutics, Inc. vs Arrowhead Pharmaceuticals, Inc.
Veracyte, Inc. vs Arrowhead Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Arrowhead Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Analysis: Comparing Arrowhead Pharmaceuticals, Inc. and MiMedx Group, Inc.